Diabetes implications: Phentermine-topiramate use is associated with improvements to numerous glycaemic markers such FBG, fasting insulin, glycated haemoglobin (HbA1c) and homeostatic model assessment of insulin resistance (HOMA-IR) (Table 1) [27, 30, 31]. Here, INS is linked to diabetes mellitus.